Triple
T7930800
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | AbbVie |
E184183
|
entity |
| Predicate | tickerSymbol |
P1447
|
FINISHED |
| Object | ABBV |
E184183
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ABBV | Statement: [AbbVie, tickerSymbol, ABBV]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ABBV Context triple: [AbbVie, tickerSymbol, ABBV]
-
A.
AbbVie
chosen
AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.
-
B.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
-
C.
Abbott
Abbott is a masculine given name of English origin, historically associated with clerical or religious roles.
-
D.
Abbott
Abbott is a common English surname borne by numerous notable individuals across fields such as politics, entertainment, science, and business.
-
E.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca8290c21c8190906a5ca6fe2b03c4 |
completed | March 30, 2026, 2:02 p.m. |
| NER | Named-entity recognition | batch_69cb3accc388819087065ebe7d5d9591 |
completed | March 31, 2026, 3:09 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69cc564a4fac8190972f9dfa7c026ea8 |
completed | March 31, 2026, 11:18 p.m. |
Created at: March 30, 2026, 5:07 p.m.